Advances in Nanocarriers for Drug Delivery and Targeting, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 1868
Special Issue Editors
Interests: nano-sized systems; drug encapsulation and delivery; drug targeting; surface functionalization; material characterization; controlled release; natural products; metal complexes; radiopharmaceuticals
Special Issues, Collections and Topics in MDPI journals
Interests: design and engineering of protein and peptide biomaterials; drug delivery; self-assembling proteins and peptides; physico-chemical stability of biomolecules; microneedle drug delivery; protein and gene carriers; adenovirus proteins; amyloid fibrils
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has emerged as an area of active investigation, especially regarding its applications in medicine. Among all these applications, nanocarrier-assisted drug delivery systems have gained increasing recognition in recent years for the development of pharmaceuticals that can be directed toward specific targets of the body to improve the therapeutic outcome while reducing side-effects.
Nanocarriers serve as viable and durable nanovehicles for the targeted delivery of bioactive compounds such as vaccines, genes, drugs, and other biomolecules, providing increased solubility and thus bioavailability, biocompatibility, physicochemical stability, protection from degradation, and controllable release profiles.
In addition, the modifiable surfaces of nanocarriers also expand their usability in different biomedical applications, especially in targeted therapy. Indeed, their modification can not only stabilize but also functionalize them to be responsive to different stimuli, improving their therapeutic efficacy.
In this Special Issue of Pharmaceutics, we invite research, and review articles that advance our knowledge of nanosized drug delivery systems. Topics include, but are not limited to, theoretical and experimental research on the synthesis and development of functionalized nanocarriers or nanoformulations with targeting potential, their physicochemical and biological characterization, nanoparticle interactions with the immune system, in vitro and in vivo studies, preclinical and clinical studies, as well as safety issues regarding their production, handling, and disposal. We look forward to receiving your contributions.
Dr. Eleftherios Halevas
Dr. Chrysoula Kokotidou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanosized systems
- drug encapsulation
- drug targeting
- surface functionalization
- biodistribution
- controlled release
- triggered release
- biological evaluation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
